Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia
Objective: To assess global improvement and patient satisfaction in participants with tardive dyskinesia (TD) who received long-term treatment with once-daily valbenazine (VBZ). Background: VBZ, approved…Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US
Objective: To investigate the incremental hourly burden of “OFF” episodes on health resource utilization (HRU) and health- related- quality of life (HRQoL) from a real…A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations
Objective: To identify the phenotypic, neuroimaging and genotype-phenotype expression of NKX6-2 mutations. Background: Despite advances in genetic testing a large number of hyopomyelinating disorders remain…A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer
Objective: To describe a patient with papillary Non-Small Cell Lung Cancer (NSCLC) who developed acute and rapidly progressive myoclonus with prominent palatal involvement as a…Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm
Objective: To investigate the differences of non-motor symptoms and the alteration of intrinsic brain networks in patients with blepharospasm and hemifacial spam. Background: Blepharospasm (BSP)…Neuromelanin Imaging and Midbrain Volumetry in Progressive Supranuclear Palsy and Parkinson’s Disease
Objective: Using neuromelanin-sensitive magnetic resonance imaging (NM-MRI) and midbrain volumetry, we analyzed differences and relationships between nigral degeneration and midbrain atrophy in PSP and PD…Long Term Response to L-dopa in Parkinson Disease
Objective: To assess the long-term effectiveness of levodopa in Parkinson’s disease (PD) patients. Background: To date, levodopa continues to be the most efficacious drug in…Objective Predictors of ‘Early Tolerance’ to Ventral Intermediate nucleus of thalamus DBS In Essential Tremor Patients
Objective: To identify pre-operative clinical and computerized spiral analysis characteristics that may help ascertain which patients with Essential Tremor (ET) will exhibit ‘early tolerance’ to…Integrated Complimentary Yoga and Ayurveda Treatment Confers Significant Benefits in PD Patients
Objective: The present study was carried out to evaluate the efficacy of integrated complimentary Yoga & Ayurveda treatment in improving the motor symptoms and also…Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease
Objective: To examine the L-dopa-response (improvement in motor symptoms) in published cases of pathologically confirmed Parkinson’s disease (PD). Background: L-dopa responsiveness supports the diagnosis of…
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 177
- Next Page »